Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Other Working Capital Changes (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Other Working Capital Changes for 6 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 50.14% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.5 million through Dec 2025, down 156.19% year-over-year, with the annual reading at -$1.5 million for FY2025, 156.19% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$1.1 million at Lexicon Pharmaceuticals, down from $358000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $2.8 million in Q2 2023, with the low at -$4.0 million in Q3 2023.
  • Average Other Working Capital Changes over 3 years is -$216416.7, with a median of -$122000.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes crashed 2687.18% in 2024, then surged 136.95% in 2025.
  • Over 3 years, Other Working Capital Changes stood at -$78000.0 in 2023, then plummeted by 2687.18% to -$2.2 million in 2024, then soared by 50.14% to -$1.1 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$1.1 million, $358000.0, and $407000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.